In colon cancer, the GABA-A receptor antagonist picrotoxin significantly reduces IL10–secreting macrophages and restores effector T cell activity, further illustrating the potential of modulating TAMs to boost anti-tumor immunity (139). The gene discussed is IL10; the disease is malignant colon neoplasm.